About WW domain-binding protein 4
WW domain-binding protein 4 (WBP4) is a protein
from Homo sapiens identified by UniProt accession
O75554, 376 residues long.
MolForge cross-references it against 0 known binders and
34 disease associations.
Target properties
| Protein name | WW domain-binding protein 4 |
| UniProt accession | O75554 |
| Gene | WBP4 |
| Organism | Homo sapiens |
| Length | 376 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (34)
Diseases linked to this target (Open Targets).
- Neurodevelopmental disorder · score 0.39
- neurodegenerative disease · score 0.34
- serum alanine aminotransferase measurement · score 0.33
- aspartate aminotransferase measurement · score 0.32
- total cholesterol measurement · score 0.29
- high density lipoprotein cholesterol measurement · score 0.26
- serum gamma-glutamyl transferase measurement · score 0.24
- alkaline phosphatase measurement · score 0.23
- apolipoprotein A 1 measurement · score 0.22
- intraocular pressure measurement · score 0.20
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O75554-F1 | alphafold | PREDICTED | 65.89 | — |
Amino-acid sequence (376 residues)
MADYWKSQPK KFCDYCKCWI ADNRPSVEFH ERGKNHKENV AKRISEIKQK SLDKAKEEEK ASKEFAAMEA AALKAYQEDL KRLGLESEIL EPSITPVTST IPPTSTSNQQ KEKKEKKKRK KDPSKGRWVE GITSEGYHYY YDLISGASQW EKPEGFQGDL KKTAVKTVWV EGLSEDGFTY YYNTETGESR WEKPDDFIPH TSDLPSSKVN ENSLGTLDES KSSDSHSDSD GEQEAEEGGV STETEKPKIK FKEKNKNSDG GSDPETQKEK SIQKQNSLGS NEEKSKTLKK SNPYGEWQEI KQEVESHEEV DLELPSTENE YVSTSEADGG GEPKVVFKEK TVTSLGVMAD GVAPVFKKRR TENGKSRNLR QRGDDQ
Explore WW domain-binding protein 4 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets